RALB and triple-negative breast carcinoma: Consistent with this hypothesis, RalB silencing was able to impair invasion (by Transwell invasion assay) of two triple-negative breast cancer cell lines: MDA-MB-231 (carrying the KRasG13D mutation) and BT549 (Ras wild-type) (Figure 7D and Figure 7—figure supplement 1D).